Publication related to RSI or an RSI staff member

Severity scoring of manganese health effects for categorical regression.

Characterizing the U-shaped exposure response relationship for manganese (Mn) is necessary for estimating the risk of adverse health from Mn toxicity due to excess or deficiency. Categorical regression has emerged as a powerful tool for exposure-response analysis because of its ability to synthesize relevant information across multiple studies and species into a single integrated analysis of all relevant data. This paper documents the development of a database on Mn toxicity designed to support the application of categorical regression techniques. Specifically, we describe (i) the conduct of a systematic search of the literature on Mn toxicity to gather data appropriate for dose-response assessment; (ii) the establishment of inclusion/exclusion criteria for data to be included in the categorical regression modeling database; (iii) the development of a categorical severity scoring matrix for Mn health effects to permit the inclusion of diverse health outcomes in a single categorical regression analysis using the severity score as the outcome variable; and (iv) the convening of an international expert panel to both review the severity scoring matrix and assign severity scores to health outcomes observed in studies (including case reports, epidemiological investigations, and in vivo experimental studies) selected for inclusion in the categorical regression database. Exposure information including route, concentration, duration, health endpoint(s), and characteristics of the exposed population was abstracted from included studies and stored in a computerized manganese database (MnDB), providing a comprehensive repository of exposure-response information with the ability to support categorical regression modeling of oral exposure data.

Authors

  • Mattison, Donald R, Mattison DR, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada; R. Samuel McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, 118-850 Peter Morand Drive, Canada. Electronic address: dmattison@risksciences.com.

  • Milton, Brittany, Milton B, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada.

  • Krewski, Daniel, Krewski D, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada; R. Samuel McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, 118-850 Peter Morand Drive, Canada.

  • Levy, Len, Levy L, Institute of Environment and Health, Cranfield University, College Road, Cranfield MK43 0AL, Bedfordshire, United Kingdom.

  • Dorman, David C, Dorman DC, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA.

  • Aggett, Peter J, Aggett PJ, School of Medicine and Health, Lancaster University, Bailrigg, Lancaster, LA1 4YW, United Kingdom.

  • Roels, Harry A, Roels HA, Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Université catholique de Louvain, Avenue Mounier 53.02, 1200 Brussels, Belgium.

  • Andersen, Melvin E, Andersen ME, ScitoVation, 6 Davis Drive, PO Box 110566, Research Triangle Park, NC, 27709-2137, USA.

  • Karyakina, Nataliya A, Karyakina NA, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada; R. Samuel McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, 118-850 Peter Morand Drive, Canada.

  • Shilnikova, Natalia, Shilnikova N, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada; R. Samuel McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, 118-850 Peter Morand Drive, Canada.

  • Ramoju, Siva, Ramoju S, Risk Sciences International, 55 Metcalfe Street, Suite 700, K1P 6L5, Ottawa, Canada.

  • McGough, Doreen, McGough D, International Manganese Institute, 17 rue Duphot, 75001 Paris, France. Electronic address: doreen.mcgough@manganese.org.

YEAR OF PUBLICATION: 2017
SOURCE: Neurotoxicology. 2017 Jan;58:203-216. doi: 10.1016/j.neuro.2016.09.001. Epub 2016 Sep 13.
JOURNAL TITLE ABBREVIATION: Neurotoxicology
JOURNAL TITLE: Neurotoxicology
ISSN: 1872-9711 (Electronic) 0161-813X (Linking)
VOLUME: 58
PAGES: 203-216
PLACE OF PUBLICATION: Netherlands
ABSTRACT:
Characterizing the U-shaped exposure response relationship for manganese (Mn) is necessary for estimating the risk of adverse health from Mn toxicity due to excess or deficiency. Categorical regression has emerged as a powerful tool for exposure-response analysis because of its ability to synthesize relevant information across multiple studies and species into a single integrated analysis of all relevant data. This paper documents the development of a database on Mn toxicity designed to support the application of categorical regression techniques. Specifically, we describe (i) the conduct of a systematic search of the literature on Mn toxicity to gather data appropriate for dose-response assessment; (ii) the establishment of inclusion/exclusion criteria for data to be included in the categorical regression modeling database; (iii) the development of a categorical severity scoring matrix for Mn health effects to permit the inclusion of diverse health outcomes in a single categorical regression analysis using the severity score as the outcome variable; and (iv) the convening of an international expert panel to both review the severity scoring matrix and assign severity scores to health outcomes observed in studies (including case reports, epidemiological investigations, and in vivo experimental studies) selected for inclusion in the categorical regression database. Exposure information including route, concentration, duration, health endpoint(s), and characteristics of the exposed population was abstracted from included studies and stored in a computerized manganese database (MnDB), providing a comprehensive repository of exposure-response information with the ability to support categorical regression modeling of oral exposure data.
COPYRIGHT INFORMATION: Copyright (c) 2016 The Authors. Published by Elsevier B.V. All rights reserved.
LANGUAGE: eng
DATE OF PUBLICATION: 2017 Jan
DATE OF ELECTRONIC PUBLICATION: 20160913
DATE COMPLETED: 20171124
DATE REVISED: 20180209
MESH DATE: 2017/11/29 06:00
EDAT: 2016/09/18 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: S0161-813X(16)30168-1 [pii] 10.1016/j.neuro.2016.09.001 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Donald Mattison

Chief Medical Officer, Senior Vice-President

Dr. Donald Mattison joined Risk Sciences International (RSI) in 2012 as Senior Vice-President and Chief Medical Officer, bringing with him a distinguished career spanning public health, clinical medicine, toxicology, and academic leadership. His appointment significantly strengthened RSI’s capacity to deliver...
Read More about Donald Mattison

Nataliya Karyakina

Senior Toxicologist, Health Risk Analyst

Dr. Nataliya Karyakina is a Senior Toxicologist and Health Risk Analyst at Risk Sciences International (RSI), where she has served since 2008. She plays a central role in RSI’s work at the intersection of chemical safety, regulatory science, and human...
Read More about Nataliya Karyakina

Natalia (Natasha) Shilnikova

Senior Health Risk Analyst

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD...
Read More about Natalia (Natasha) Shilnikova